title: Methylene blue treatment in experimental ischemic stroke: a mini review.
abstract: Stroke is a leading cause of death and long-term disability. Methylene blue, a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neurodegenerative diseases and brain injuries. The goal of this paper is to review studies on methylene blue in experimental stroke models.
authors.affiliation: Research Imaging Institute, Radiology, University of Texas Health Science Center, San Antonio, Texas, USA.
authors.forename: Zhao
authors.initials: Z
authors.lastname: Jiang
authors.affiliation: Department of Ophthalmology, Radiology and Physiology, University of Texas Health Science Center, San Antonio, Texas, USA.
authors.forename: Timothy Q
authors.initials: TQ
authors.lastname: Duong
keywords: Ischemia; Methylene blue; Stroke